Latest News about MORF
Recent news which mentions MORF
Benzinga's Top Ratings Upgrades, Downgrades For August 9, 2023
August 09, 2023
From Benzinga
From Benzinga
3 Stocks That Could Skyrocket by This Time Next Summer
June 08, 2023
From InvestorPlace
More Than $47M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
May 05, 2023
From Benzinga
3 Biotech Buyout Targets to Watch
April 29, 2023
From Motley Fool
Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 25, 2023
From Benzinga
From Benzinga
Morphic Therapeutic's Ulcerative Colitis Candidate Shows Clinically Meaningful Improvements Across Measures, Stock Soars
April 25, 2023
Tickers
MORF
From Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
April 25, 2023
From Benzinga
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 17, 2023
From Benzinga
7 Biotech Stocks to Buy for 100% Returns
April 09, 2023
From InvestorPlace
Looking Into Morphic Holding's Return On Capital Employed
February 28, 2023
Tickers
MORF
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
September 07, 2022
From Benzinga
From Benzinga
Wells Fargo Maintains Overweight Rating for Morphic Holding: Here's What You Need To Know
May 05, 2022
Tickers
MORF
From Benzinga
71 Biggest Movers From Yesterday
April 27, 2022
From Benzinga
34 Stocks Moving In Tuesday's Mid-Day Session
April 26, 2022
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
April 20, 2022
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 8, 2021
December 08, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.